CohBar

CohBar engaged in the research and development of mitochondria-based therapeutics. Read more

Joseph J. Sarret's photo - CEO of CohBar

CEO

Joseph J. Sarret

CEO Approval Rating

- -/100

Founded:

2007

Status:

PublicIndependent CompanyNASDAQCWBR

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of CohBar?

CohBar Quarterly and Annual Revenue

Coming soon for CohBar!

Annual Revenue

$4.1M

CohBar Acquisitions

No recent acquisitions found related to CohBar

CohBar Funding History

Since CohBar was founded in 2007, it has participated in 5 rounds of funding. In total CohBar has raised $22.9M. CohBar's last funding round was on Apr 2018 for a total of $3.9M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Apr 2018
$3.9M
-
Private Placement
Mar 2018
$2.1M
-
Private Placement
Jul 2017
$5.2M
-
IPO
Jan 2015
$11.3M

Equity
Feb 2014
$450K
-

Since CohBar was founded in 2007, it has participated in 5 rounds of funding. In total CohBar has raised $22.9M. CohBar's last funding round was on Apr 2018 for a total of $3.9M

CohBar Investments

No recent investments found related to CohBar

CohBar News

April 27, 2021GlobeNewswire

CohBar Appoints Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and Director

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based the... See more »
March 30, 2021Seeking Alpha

CohBar Q4 EPS misses by $0.03

March 23, 2021The Pharma Letter

CohBar discoveries "a shocker to scientists" says CEO

Californian aging specialist CohBar is using mitochondrial science to treat diseases, but chief execu... See more »
March 17, 2021Markets Insider

CohBar to Announce 2020 Fourth Quarter Financial Results and Provide Business Update on March 30, 2021

MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage ... See more »
March 16, 2021Markets Insider

CohBar Nominates CB5138 Analog as Lead Clinical Candidate for Idiopathic Pulmonary Fibrosis and other Fibrotic Diseases

MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage ... See more »
March 12, 2021Benzinga

CohBar to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

MENLO PARK, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage b... See more »

CohBar Press Releases

April 14, 2021centralcharts

CohBar to Present at the Mitochondria-Targeted Drug Development Summit

MENLO PARK, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage ... See more »
March 30, 2021StreetInsider

CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update

MENLO PARK, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage ... See more »
March 29, 2021GlobalNewswire

CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity

MENLO PARK, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage ... See more »
March 2, 2021GlobeNewswire

CohBar to Present at the 33rd Annual ROTH Conference

MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage ... See more »
February 25, 2021GlobeNewswire

CohBar to Present at the H.C. Wainwright Global Life Sciences Conference

MENLO PARK, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage b... See more »
February 9, 2021GlobeNewswire

CohBar to Present at the BIO CEO & Investor Digital Conference

MENLO PARK, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage b... See more »
January 20, 2021centralcharts

CohBar to Present at the 3rd Annual Longevity Therapeutics Conference

MENLO PARK, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage b... See more »

Social Media

CohBar Headquarters

1455 Adams Drive Suite 2050

Menlo Park, California94025

650-446-7888

Driving Directions »

Trending Companies

CohBar Summary

ABOUT

Overview

CohBar engaged in the research and development of mitochondria-based therapeutics. CohBar was founded in 2007. CohBar's headquarters is located in Menlo Park, California, USA 94025. It has raised 22.9M in 5 rounds. The latest round was in Apr 2018. Co...

Website

cohbar.com

Frequently Asked Questions about CohBar

  1. When was CohBar founded?

    CohBar was founded in 2007
  2. Who is CohBar's CEO?

    CohBar's CEO is Joseph J. Sarret
  3. How much revenue does CohBar generate?

    CohBar generates $4.1M in revenue
  4. How much funding does CohBar have?

    CohBar has historically raised $22.9M in funding
  1. Where is CohBar's headquarters?

    CohBar's headquarters is in Menlo Park California, USA
  2. How many employees does CohBar have?

    CohBar has 11 employees
  3. What sector does CohBar operate in?

    CohBar is in Biotechnology